Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

Share Price is delayed by 15 minutes
Get Live Data
2,390.00    0.00 (0.00%)
Bid:
2,000.00
Ask:
2,450.00
Spread: 450.00 (22.50%)
Market Cap: £7.67b
BNZL Live PriceLast checked at - London Stock Exchange

Intraday Bunzl Share Chart

Trading Statement

22 Apr 2026 07:00

RNS Number : 3653B
Bunzl PLC
22 April 2026
 

22 April 2026

BUNZL Q1 TRADING STATEMENT

TRADING CONSISTENT WITH EXPECTATIONS; 2026 GUIDANCE UNCHANGED

 

Bunzl plc, the specialist international distribution and services Group, today announces its trading statement for the three month period to 31 March 2026.

 

Bunzl has delivered a resilient performance in the first quarter against a backdrop of significant macroeconomic and geopolitical uncertainty. Group revenue in the period grew by 1.5% at constant exchange rates, with underlying revenue1 increasing by 2.0%, supported by both volume growth, in part reflective of easier comparatives, and tariff-related price increases. Acquisitions net of disposals contributed growth of 0.6%, while fewer trading days in the period impacted revenue by 1.1%. At actual exchange rates, Group revenue decreased by 0.4%. Adjusted operating profit over the period was consistent with our expectations for a more stable performance in 2026.

 

North America's underlying revenue growth was slightly ahead of the Group, supported by continued benefit of actions taken to improve performance, including new business won in the second half of 2025. Across the other business areas we saw slight underlying revenue growth in aggregate.

 

While the current geopolitical and macroeconomic environment has become more uncertain, we reiterate our 2026 guidance with performance year-to-date consistent with our expectations. We continue to expect moderate revenue growth at constant exchange rates, driven by some underlying revenue growth and a small benefit from acquisitions, and operating margin to be slightly down year-on-year.

 

Commenting on today's announcement, Frank van Zanten, Chief Executive Officer of Bunzl, said:

 

"The Group continued to deliver underlying revenue growth in the first quarter, supported by actions taken to improve performance and our strengthened focus on organic revenue opportunities. While mindful of the current economic and geopolitical backdrop, the Group reiterates its full year guidance and expects 2026 to be a foundation for future profit growth. Furthermore, there continues to be a significant consolidation opportunity; our pipeline is active and we see an improved outlook for acquisitions in 2026 compared to the prior year. I remain fully confident in our ability to generate long-term compounding growth and value creation for all of our stakeholders."

 

 

 

Enquiries:

Bunzl plc

Frank van Zanten, Chief Executive Officer

Richard Howes, Chief Financial Officer

Sunita Entwisle, Head of Investor Relations and Communications

Tel: +44 (0)20 7725 5000

Teneo

Martin Robinson

Kate Somerville

Tel: +44 (0)20 7353 4200

 

 

1. Underlying revenue is organic revenue adjusted for trading days and net of the benefit of hyperinflationary growth in excess of 26% per annum in Turkey, which had no impact over this period.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBSGDSGXDDGLB
Date   Source Headline
1st Apr 202211:13 amRNSTotal Voting Rights
17th Mar 20224:15 pmRNSAnnual Financial Report
15th Mar 202211:30 amRNSDirector Declaration
3rd Mar 20225:07 pmRNSDirector/PDMR Shareholding
2nd Mar 20226:12 pmRNSDirector/PDMR Shareholding
2nd Mar 20225:36 pmRNSDirector/PDMR Shareholding
1st Mar 20225:58 pmRNSDirector/PDMR Shareholding
1st Mar 20223:00 pmRNSTotal Voting Rights
1st Mar 20229:00 amRNSDirector Declaration
28th Feb 20227:00 amRNSAnnual Financial Report
3rd Feb 20224:06 pmRNSDirector/PDMR Shareholding
2nd Feb 20225:30 pmRNSDirectorate Change
1st Feb 202210:58 amRNSTotal Voting Rights
12th Jan 202212:15 pmRNSDirector/PDMR Shareholding
12th Jan 20227:00 amRNSAcquisition
10th Jan 20225:34 pmRNSDirector/PDMR Shareholding
7th Jan 202211:54 amRNSDirector/PDMR Shareholding
4th Jan 20225:56 pmRNSTotal Voting Rights
15th Dec 20217:00 amRNSTrading Statement
10th Dec 20213:18 pmRNSDirector/PDMR Shareholding
8th Dec 20214:30 pmRNSDirector Declaration
8th Dec 20218:00 amRNSAdditional Listing
3rd Dec 20214:27 pmRNSDirector/PDMR Shareholding
1st Dec 20214:50 pmRNSDirector/PDMR Shareholding
1st Dec 202110:20 amRNSTotal Voting Rights
18th Nov 20217:00 amRNSAcquisition
10th Nov 20213:00 pmRNSPublication of Admission Particulars
4th Nov 20215:41 pmRNSDirector/PDMR Shareholding
3rd Nov 202112:35 pmRNSDirector/PDMR Shareholding
3rd Nov 202112:35 pmRNSDirector/PDMR Shareholding
1st Nov 20213:14 pmRNSTotal Voting Rights
1st Nov 20219:00 amRNSBlock listing Interim Review
29th Oct 20211:10 pmRNSDirector/PDMR Shareholding
26th Oct 20217:00 amRNSTrading Statement
19th Oct 20215:12 pmRNSDirector/PDMR Shareholding
19th Oct 20215:11 pmRNSDirector/PDMR Shareholding
11th Oct 20217:00 amRNSCapital Markets Day
8th Oct 20212:28 pmRNSDirector/PDMR Shareholding
8th Oct 20212:24 pmRNSDirector/PDMR Shareholding
5th Oct 202110:16 amRNSDirector/PDMR Shareholding
1st Oct 202112:36 pmRNSTotal Voting Rights
14th Sep 20217:00 amRNSAcquisition
3rd Sep 202112:30 pmRNSDirector/PDMR Shareholding
1st Sep 20214:00 pmRNSTotal Voting Rights
31st Aug 20214:30 pmRNSDividend Declaration
31st Aug 20217:00 amRNSHalf-year Report
31st Aug 20217:00 amRNSAcquisition
4th Aug 202111:24 amRNSDirector/PDMR Shareholding
2nd Aug 20213:40 pmRNSTotal Voting Rights
14th Jul 20214:11 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.